Skip Navigation

Cardiovascular Research 2003 58(3):712-720; doi:10.1016/S0008-6363(03)00257-8
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ahmed, Z.
Right arrow Articles by Connelly, P. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahmed, Z.
Right arrow Articles by Connelly, P. W
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Formation of apolipoprotein AI–phosphatidylcholine core aldehyde Schiff base adducts promotes uptake by THP-1 macrophages

Zakaria Ahmeda, Amir Ravandib, Graham F Maguirec, Arnis Kuksisb and Philip W Connellyc,d,e,f,*

aDepartment of Pathology and Laboratory Medicine, University of Louisville Medical Center, Louisville, KY 40202, USA
bBanting and Best Department of Medical Research, University of Toronto, Toronto, Canada
cJ. Alick Little Lipid Research Laboratory, St. Michael's Hospital, 38 Shuter Street, Room 1004 WA, Toronto, Ontario M5B 1A6, Canada
dDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
eDepartment of Biochemistry, University of Toronto, Toronto, Canada
fDepartment of Medicine, University of Toronto, Toronto, Canada

connellyp{at}smh.toronto.on.ca

* Corresponding author. Tel.: +1-416-864-6023; fax: +1-416-864-5870.

Objective: High-density lipoprotein (HDL) is believed to protect against development of atherosclerosis by inhibiting the accumulation of oxidized lipids in low-density lipoprotein (LDL). Paradoxically, HDL lipid is more susceptible to oxidation than LDL lipid. In the present study, we examined the effect of oxidized phospholipids on the uptake of HDL by macrophages. Methods and results: Oxidation of HDL increased formation of phosphatidylcholine core aldehydes that was paralleled by increased covalent binding of phospholipids to HDL protein from 0.96±0.44 to 8.5±1.76 phosphorus/HDL protein (mol/mol). Incubation of apolipoprotein AI with synthetically prepared phosphatidylcholine core aldehydes, 1-palmitoyl-2-[5-oxo]valeroyl-sn-glycero-3-phosphocholine or 1-palmitoyl-2-[9-oxo] nonanoyl-sn-glycero-3-phosphocholine, significantly increased the phosphorus:apolipoprotein AI ratio from 1.1±0.5 to 7.2±2.0 and from 0.9±0.6 to 8.5±0.8, respectively. The binding and uptake of phosphatidylcholine core aldehyde–apolipoprotein AI proteoliposomes, by THP-1 macrophages, was similar to that observed for oxidized HDL and oxidized LDL. Conclusion: We conclude that oxidation of HDL increased formation of phosphatidylcholine core aldehyde–apolipoprotein AI Schiff base adducts and enhanced uptake of oxidized HDL by THP-1 macrophages.

KEYWORDS ApoAI, apolipoprotein AI; DiI, 1,1'-dioctadecyl-3,3,3'3'tetramethyl-indocarbocyanine perchlorate; DiO, 3,3'dihexadecyloxacarbocyanine perchlorate; DMPC, dimyristoyl phosphatidylcholine; HDL, high-density lipoproteins; LDL, low-density lipoproteins; PC, phosphatidylcholine; POVPC, 1-palmitoyl-2-[5-oxo]valeroyl-sn-glycero-3-phosphocholine; LC–ESI-MS, liquid chromatography–electrospray ionization-mass spectrometry; PONPC, 1-palmitoyl-2-(9-oxo)nonanoyl-sn-glycero-3-phosphocholine; SDS– PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
A. Moumtzi, M. Trenker, K. Flicker, E. Zenzmaier, R. Saf, and A. Hermetter
Import and fate of fluorescent analogs of oxidized phospholipids in vascular smooth muscle cells
J. Lipid Res., March 1, 2007; 48(3): 565 - 582.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev, April 1, 2006; 86(2): 515 - 581.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.